Prevalence of depression and anxiety in adult patients with β-thalassemia major and intermedia

International Journal of Psychiatry in Medicine

Volumn 44, Issue 4, 2012, Pages 291-303

  Khoury, Brigitte ^a   Musallam, Khaled M ^a   Abi Habib, Rudy ^a   Bazzi, Lama ^a   Koussa, Suzanne ^a   Taher, Ali T ^a   Al Ward, Zainab ^a   Succar, Julien ^a   Halawi, Racha ^b   Hankir, Ahmed ^a,b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b Chronic Care Center Hazmieh   (Lebanon)

Author keywords

Anxiety; Depression; Thalassemia

Indexed keywords

ADULT; ANXIETY; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PREVALENCE; RISK FACTOR; SCORING SYSTEM; SOCIAL STATUS; THALASSEMIA MAJOR; ADOLESCENT; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; ADULT; ANXIETY; BETA-THALASSEMIA; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84881623681     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.44.4.a     Document Type: Article

References (33)

1. Weatherali DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010;115:4331-4336.
2. Rund D, Rachmilewitz E. Beta-thalassemia. New England Journal of Medicine 2005;353:1135-1146.
3. Sankaran VG, Lettre G, Orkin SH, Hirschhom JN. Modifier genes in Mendelian disorders: The example of hemoglobin disorders. Annals of the New York Academy of Sciences 2010;1214:47-56.
4. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood 2011;118:3479-3488.
5. Taher AT, Musallam KM, Cappellini MD, Weatherall DJ. Optimal management of beta thalassaemia intermedia. British Journal of Haematology 2011;152:512-523.
6. Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, Singer T, Vichinsky EP. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Annals of the New York Academy of Sciences 2005;1054:457-461.
7. Musallam KM, Khoury B, Abi-Habib R, Bazzi L, Succar J, Halawi R, Hankir A, Koussa S, Taher AT. Health-related quality of life in adults with transfusionindependent thalassaemia intermedia compared to regularly transfused thalassaemia major: New insights. European Journal of Haematology 2011;87:73-79.
8. Sobota A, Yamashita R, Xu Y, Trachtenberg F, Kohlbry P, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V, Porter JB, Thompson AA, Schilling L, Quinn CT, Neufeld EJ. Quality of life in thalassemia: A comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. American Journal of Hematology 2011;86:92-95.
9. Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta thalassemiamajor/intermedia. Journal of Research in Medical Sciences 2009;14:349-355.
10. Musallam K, Cappellini MD, Taher A. Challenges associated with prolonged survival of patients with thalassemia: Transitioning from childhood to adulthood. Pediatrics 2008;121: e 1426-e 1429.
11. Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V, Porter JB, Thompson AA, Schilling L, Quinn CT, Neufeld EJ, Yamashita R. Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort. American Journal of Hematology 2010;85:802-805.
12. Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C, Cappellini MD. Psychosocial aspects and psychiatric disorders in young adult with thalassemia major. Internal and Emergency Medicine 2008;3:339-343.
13. West J. An Arabic validation of a depression inventory. International Journal of Social Psychiatry 1985;31:282-289.
14. Beck AT. Depression: Causes and treatment. Philadelphia, PA: University of Pennsylvania Press, 2006.
15. Abdullatif QA. Adaptation of the state trait anxiety inventory in Arabic: A comparison with the American STAI. Tampa, FL: University of South Florida, Department of Psychology, 2004:55.
16. Speilberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA. The state-trait anxiety inventory for adults manual. Palo Alto, CA: Mind Garden, 1983.
17. Lisspers J, Nygren A, Söderman E. Hospital Anxiety and Depression Scale (HAD):Some psychometric data for a Swedish sample. Acta Psychiatrica Scandinavica 1997;96:281-286.
18. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, Lai ME, Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S, Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. Clinical Therapeutics 2007;29:909-917.
19. Taher A, Al Jefri A, Elalfy MS, Al Zir K, Daar S, Rofail D, Baladi JF, Habr D, Kriemler-Krahn U, El-Beshlawy A. Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-thalassemia: Results from the ESCALATOR Trial. Acta Haematologica 2010;123:220-225.
20. Borras L, Constant E. Depression and beta-thalassemia: A genetic link? Acta Neuropschiatrica 2007;19:134.
21. Pradhan PV, Shah H, Rao P, Ashturkar D, Ghaisas P. Psychopathology and self-esteem in chronic illness. Indian Journal of Pediatrics 2003;70:135-138.
22. Mikelli A, Tsiantis J. Brief report: Depressive symptoms and quality of life in adolescents with β-thalassaemia. Journal of Adolescence 2004;27:213-216.
23. Sabry N, Salama KH. Cognitive abilities, mood changes and adaptive functioning in children with βthalassaemia. Currrent Psychiatry 2009;16:244-254.
24. Di Palma A, Vullo C, Zani B, Facchini A. Psychosocial integration of adolescents and young adults with thalassemia major. Annals of the New York Academy of Sciences 1998;850:355-360.
25. McPherson M, Thaniel L, Minniti CP. Transition of patients with sickle cell disease from pediatric to adult care: Assessing patient readiness. Pediatric Blood and Cancer 2009;52:838-841.
26. Levine L, Levine M. Health care transition in thalassemia: Pediatric to adultoriented care. Annals of the New York Academy of Sciences 2010;1202:244-247.
27. Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A. Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. Journal of Thrombosis and Haemostasis 2010;8:54-59.
28. Musallam KM, Beydoun A, Hourani R, Nasreddine W, Raad R, Koussa S, Taher AT. Brain magnetic resonance angiography in splenectomized adults with beta-thalassemia intermedia. European Journal of Haematology 2011;87:539-546.
29. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA. Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia. Thrombosis and Haemostasis 2010;103:989-993.
30. Manfre L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: Findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR American Journal of Roentgenology 1999;173:1477-1480.
31. Musallam KM, Nasreddine W, Beydoun A, Hourani R, Hankir A, Koussa S, Haidar M, Taher AT. Brain positron emission tomography in splenectomized adults with beta-thalassemia intermedia: Uncovering yet another covert abnormality. Annals of Hematology 2012;91:235-241.
32. Ma N, Li L, Shu N, Liu J, Gong G, He Z, Li Z, Tan L, Stone WS, Zhang Z, Xu L, Jiang T. White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder. American Journal of Psychiatry 2007;164:823-826.
33. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: A review of the epidemiology, risk and treatment evidence. Medical Journal of Australia 2009;190:54-60.